Medical interventions for high grade vulval intraepithelial neoplasia

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2011, Pages

  Pepas, Litha ^a   Kaushik, Sonali ^b   Bryant, Andrew ^c   Nordin, Andy ^a   Dickinson, Heather O ^c  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; CIDOFOVIR; IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; INDOLE-3-CARBINOL;

BODY IMAGE; CANCER GROWTH; CANCER RECURRENCE; COMORBIDITY; FOLLOW UP; HIGH GRADE VULVAL INTRAEPITHELIAL NEOPLASIA; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; SEXUALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; VULVA CANCER; VULVECTOMY; ADULT; CARCINOMA IN SITU; FEMALE; META ANALYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOPICAL DRUG ADMINISTRATION; VULVA TUMOR;

ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; CARCINOMA IN SITU; FEMALE; HUMANS; INDOLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VULVAR NEOPLASMS;

EID: 79955675091     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007924.pub2     Document Type: Review

References (56)

1. Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomised, double-blinded study. Gynecologic Oncology 2007;107(2):219-22.
2. Naik R, Nixon S, Lopes A, Godfrey K, Hatem MH, Monaghan JM. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. International Journal of Gynecological Cancer 2006; Vol. 16, issue 2:786-90.
3. Sterling J C, Smith NA, Loo WJ, Cohen C, Neill S, Nicholson A, et al.Randomized, double blind, placebo-controlled trial for treatment of high grade vulval intraepithelial neoplasia with imiquimod. Abstract FC06.1. Journal of the European Academy of Dermatology and Venereology 2005; Vol. 19, issue Suppl 2:22.
4. Terlou A, van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, et al.Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial. Gynecologic Oncology 2011:doi:10.1016/j.ygyno.2010.12.340.
5. van Seters M, van Beurden M, Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al.Treatment of vulvar intraepithelial neoplasia with topical imiquimod. New England Journal of Medicine 2008;358(14):1465-73.
6. Iavazzo C, Pitsouni E, Athanasiou S, Falagas ME. Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia. International Journal of Gynaecology and Obstetrics 2008;101(1):3-10.
7. Mahto M, Nathan M, OMahony C. More than a decade on: review of the use of imiquimod in lower anogenital intraepithelial neoplasia. International Journal of STD & AIDS 2010;21(1):8-16.
8. Mathiesen O. Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomised, double blinded study - an answer. Gynecological Oncology 2008;109(3):431.
9. Melamed E L. Precancerous lesions of the vulva and therapeutic methods. Data from the Leningrad Municipal oncological dispensary. [Russian]. Voprosy 1965;Onkologii:85-9.
10. Spirtos N M, Smith L H, Teng N N. Prospective randomized trial of topical alpha-interferon (alpha-interferon gels) for the treatment of vulvar intraepithelial neoplasia III. Gynecol Oncol 1990;37(1):34-8.
11. Spirtos NM, Smith LH, Teng NNH. A prospective, randomized trial of topical interferon-alpha (INF) gels for the treatment of vulvar intraepithelial neoplasia III (VIN III). Gynecological Oncology 1989; Vol. 32, issue 1:112, Abstract 76.
12. Todd RW, Luesley DM. Medical management of vulvar intraepithelial neoplasia. Journal of Lower Genital Tract Diseases 2005;9(4):206-12.
13. van de Nieuwenhof HP, van der Avoort IA, Massuger LF, de Hullu JA. Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study. Gynecological Oncology 2008;109(3):430-1; author reply 431.
14. Fiander A. A randomised phase II multi-centre clinical trial of topical treatment in women with vulval intraepithelial neoplasia. [RT3VIN]. ISRCTN34420460.
15. Andreasson B, Moth I, Jensen SB, Bock JE. Sexual function and somatopsychic reactions in vulvectomy-operated women and their partners. Acta Obstetricia et Gynecologica Scandinavica 1986;65(1):7-10.
16. Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, et al.Placebo-Controlled Trial of Indole-3-Carbinol in the Treatment of CIN. Gynecologic Oncology 2000;78(2):123-9.
17. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
18. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration 2008, issue Version 5.0.1:www.cochrane-handbook.org.
19. CTCAE . Common Terminology Criteria for Adverse Events. (http://ctep.cancer.gov/forms/CTCAEv3.pdf) 9th August 2006; Vol. v3.0 (CTCAE).
20. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. International Journal of Cancer 2009 Apr 1;124(7):1626-36.
21. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG (eds). Systematic Reviews in Health Care: Meta-Analysis in Context (2nd edition). London: BMJ Publication Group 2001.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
23. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, et al.Photodynamic therapy. Journal of National Cancer Institute 1998 Jun 17;90(12):889-905.
24. Fehr MK, Hornung R, Schwarz VA, Simeon R, Haller U, Wyss P. Photodynamic Therapy of Vulvar Intraepithelial Neoplasia III UsingTopically Applied 5-Aminolevulinic Acid. Gynecologic Oncology 2001;80(1):62-6.
25. Foster DC, Woodruff JD. The use of dinitrochlorobenzene in the treatment of vulvar carcinoma in situ. Gynecological Oncology 1981 Jun;11(3):330-9.
26. Garrat AM, Torgerson DJ, Wyness J, Hall MH, Reid DM. Measuring sexual function in premenopausal women. British Journal of Obstetrics and Gynaecolgy 1995;102:311-5.
27. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-94.
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
29. Hillemanns P, Untch M, Dannecker C. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. International Journal of Cancer 2000;85(5):649-53.
30. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents. IARC Scientific Publication No. 155, Lyon 2002; Vol. Volume VIII.
31. Jones RW, Baranyai J, Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstetrics and Gynecology 1997;90(3):448-52.
32. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstetrics and Gynecology 2005 Dec;106(6):1319-26.
33. Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. Journal of Reproductive Medicine 2000;45(8):613-5.
34. Kauffman RH. Intraepithelial neoplasia of the vulva. Gynecological Oncology 1995;15(1):8-21.
35. Kaushik S, Pepas L, Nordin A, Bryant A, Dickinson HO. Surgical interventions for high grade vulval intraepithelial neoplasia. Cochrane Database of Systematic Reviews 2011;1:Art. No.: CD007928. [DOI: CD007928]
36. Kuppers V, Stiller M, Somville T, Bender HG. Risk factors for recurrent VIN: role of multifocal and grade of disease. Journal of Reproductive Medicine 1997;42(3):140-4.
37. Le T, Menard C, Hicks-Boucher W. Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecologic Oncology 2007;106(3):579-84.
38. Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: A randomised double-blinded study. Gynecologic Oncology 2007;107(2):219-22.
39. Moore RA, Edwards JE, Hopwood J, Hicks D. Imiquimod for the treatment of genital warts: a quantitative systematic review. BMC Infectious Diseases 2001;1:3.
40. Narayansingh GV, Cumming GP, Parkin DP, McConell DT, Honey E, Kolhe PS. Flap Repair: an effective strategy for minimising sexual morbidity associated with the surgical management of vulval intraepithelial neoplasia. Journal of the Royal College of Surgeons of Edinburgh 2000;45(2):81-4.
41. Newfield L, Bradlow HL, Sepkovic DW, Auborn K. Estrogen metabolism and the malignant potential of human papilloma virus immortalised keratinocytes. Proceedings of the Society for Experimental Biology and Medicine 1998;217:322-6.
42. Office for National Statistics. Cancer Registrations in England. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=8843 2004.
43. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
44. Roberts JA, Watring WG, Lagasse LD. Treatment of vulvar intraepithelial neoplasia (VIN) with local bleomycin. Cancer Clinical Trials 1980;3(4):351-4.
45. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, et al.Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee. Journal of the Reproductive Medicine 2005;50(11):807-10.
46. Sillman FH, Sedlis A, Boyce JG. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstetrical and Gynecological Survey 1985;40(4):190-220.
47. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstetrics and Gynecology 2009;113(4):917-24.
48. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clinical Expiremental Dermatology 2002;27(7):571-7.
49. Terlou A, van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, et al.Treatment of vulvar intraepithelial neoplasia with topical imiquimod: Seven years median follow-up of a randomized clinical trial. Gynecologic Oncology 2011; Vol. Jan (Epub ahead of print).
50. Todd RW, Etherington IJ, Leusley DM. The effects of 5% imiquimod on high-grade vulval intraepithelial neoplasia. Gynecologic Oncology 2001;85:67-70.
51. Tristram A, Fiander A. Clinical responses to cidofovir applied topically to women with high grade vulval intraepithelial neoplasia. Gynecologic Oncology 2005;99(3):652-5.
52. Van Seters M, Fons G, van Beurden M. Imiquimod in the treatment of multifocal vulval intraepithelial neoplasia 2/3. Results of a pilot study. Journal of Reproductive Medicine 2002;47(9):701-5.
53. van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecologic Oncology 2005 May;97(2):645-51.
54. Welsh Cancer Intelligence and Surveillance Unit. Cancer Registrations in Wales. http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=18135 2000-2004.
55. Wendling J, Saiag P, Bervill-Levy S, Bourgault-Villada I, Clerici T, Moyal-Barracco M. Treatment of undifferentiated vulvar intraepithelial neoplasia with 5% imiquimod cream. A prospective study of 12 cases. Archives of Dermatology 2004;140:1229-4.
56. Winters U, Daayana S, Lear JT, Tomilson AE, Elkord E, Stern PL, et al.Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia. Clinical Cancer Research 2008;14(16):5292-99.